Biotech ETFs Could See More Inflows
After languishing in the latter stages of 2018, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund…
XBI
SPDR S&P Biotech ETF
$85.74 +$1.65
(+1.96%)
As of 1:00:00 AM EDT | 2/22/19 | Market Closed
XBI Trading Data
Open
$84.5
Low Price
$83.99
High Price
$85.88
Previous Last Price
$84.09
Bid Size
$0 X 0
Ask Size
$0 X 0
XBI Portfolio Data
AUM
$4,017,112,000
Shares
47,800
PE Ratio
17.32
Price / Book Ratio
4.4
Expense Ratio
0.35
Net Asset Value
$84.04
Volume
Volume
3,407,800
Avg. Volume (YDT)
4,591,086
Dollar Volume
$257,190,027
Weekly Avg. Volume
4,233,180
Monthly Avg. Volume
3,660,870
Quarterly Avg. Volume
5,604,344
XBI Fund Description
The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.
XBI Chart
XBI Summary
Fund Family
State Street Global Advisors
Tracks This Index
SPDR S&P Biotech ETF
Inception Date
2006-01-31
Asset Class
Equity
Asset Class Size
Biotech
XBI Classification
Region (General)
North America
Region (Specific)
US
Sector
Health Care
Equity Index
Leveraged Family
XBI Holdings
Top 10 Holdings
Mirati Therapeutics Inc. (MRTX)
2.12%
Portola Pharmaceuticals Inc. (PTLA)
1.94%
SAGE Therapeutics Inc. (SAGE)
1.81%
Array BioPharma Inc. (ARRY)
1.79%
Celgene Corporation (CELG)
1.64%
FibroGen Inc. (FGEN)
1.61%
Ultragenyx Pharmaceutical Inc. (RARE)
1.6%
ACADIA Pharmaceuticals Inc. (ACAD)
1.59%
Incyte Corporation (INCY)
1.59%
bluebird bio Inc. (BLUE)
1.55%
Total XBI Holdings
Total Holdings: 121
Mirati Therapeutics Inc. (MRTX)
2.12%
Portola Pharmaceuticals Inc. (PTLA)
1.94%
SAGE Therapeutics Inc. (SAGE)
1.81%
Array BioPharma Inc. (ARRY)
1.79%
Celgene Corporation (CELG)
1.64%
FibroGen Inc. (FGEN)
1.61%
Ultragenyx Pharmaceutical Inc. (RARE)
1.6%
ACADIA Pharmaceuticals Inc. (ACAD)
1.59%
Incyte Corporation (INCY)
1.59%
bluebird bio Inc. (BLUE)
1.55%
Exact Sciences Corporation (EXAS)
1.54%
Global Blood Therapeutics Inc (GBT)
1.49%
Spark Therapeutics Inc. (ONCE)
1.49%
Alexion Pharmaceuticals Inc. (ALXN)
1.47%
Clovis Oncology Inc. (CLVS)
1.47%
Puma Biotechnology Inc. (PBYI)
1.46%
Seattle Genetics Inc. (SGEN)
1.44%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.44%
Sarepta Therapeutics Inc. (SRPT)
1.44%
Madrigal Pharmaceuticals Inc. (MDGL)
1.44%
Heron Therapeutics Inc (HRTX)
1.41%
Regeneron Pharmaceuticals Inc. (REGN)
1.38%
Agios Pharmaceuticals Inc. (AGIO)
1.37%
United Therapeutics Corporation (UTHR)
1.37%
Ionis Pharmaceuticals Inc. (IONS)
1.37%
Neurocrine Biosciences Inc. (NBIX)
1.37%
Vertex Pharmaceuticals Incorporated (VRTX)
1.36%
Amicus Therapeutics Inc. (FOLD)
1.35%
Biogen Inc. (BIIB)
1.28%
Myriad Genetics Inc. (MYGN)
1.28%
Exelixis Inc. (EXEL)
1.27%
Blueprint Medicines Corp. (BPMC)
1.27%
Arena Pharmaceuticals Inc. (ARNA)
1.26%
Gilead Sciences Inc. (GILD)
1.26%
REGENXBIO Inc. (RGNX)
1.26%
Alnylam Pharmaceuticals Inc (ALNY)
1.25%
Alkermes Plc (ALKS)
1.25%
Enanta Pharmaceuticals Inc. (ENTA)
1.24%
Amgen Inc. (AMGN)
1.21%
Viking Therapeutics Inc. (VKTX)
1.2%
BioMarin Pharmaceutical Inc. (BMRN)
1.2%
AnaptysBio Inc. (ANAB)
1.17%
PTC Therapeutics Inc. (PTCT)
1.17%
Esperion Therapeutics Inc. (ESPR)
1.16%
AbbVie Inc. (ABBV)
1.16%
Insmed Incorporated (INSM)
1.15%
Genomic Health Inc. (GHDX)
1.12%
Repligen Corporation (RGEN)
1.1%
Emergent BioSolutions Inc. (EBS)
1.09%
Ligand Pharmaceuticals Incorporated (LGND)
1.08%
Intercept Pharmaceuticals Inc. (ICPT)
1.07%
Invitae Corp. (NVTA)
1.01%
Immunomedics Inc. (IMMU)
0.96%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.92%
Spectrum Pharmaceuticals Inc. (SPPI)
0.91%
Atara Biotherapeutics Inc (ATRA)
0.84%
CareDx Inc. (CDNA)
0.84%
Sangamo Therapeutics Inc. (SGMO)
0.83%
Acceleron Pharma Inc (XLRN)
0.73%
ImmunoGen Inc. (IMGN)
0.73%
Halozyme Therapeutics Inc. (HALO)
0.68%
Radius Health Inc (RDUS)
0.67%
Intrexon Corporation (XON)
0.64%
Aimmune Therapeutics Inc (AIMT)
0.63%
Coherus BioSciences Inc. (CHRS)
0.63%
OPKO Health Inc. (OPK)
0.62%
Natera Inc. (NTRA)
0.62%
Iovance Biotherapeutics Inc (IOVA)
0.62%
Cara Therapeutics Inc (CARA)
0.62%
Audentes Therapeutics Inc. (BOLD)
0.62%
Editas Medicine Inc. (EDIT)
0.62%
Eagle Pharmaceuticals Inc. (EGRX)
0.6%
Alder Biopharmaceuticals Inc. (ALDR)
0.59%
Verastem Inc. (VSTM)
0.58%
Vericel Corporation (VCEL)
0.58%
AMAG Pharmaceuticals Inc. (AMAG)
0.54%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.53%
Flexion Therapeutics Inc. (FLXN)
0.53%
Momenta Pharmaceuticals Inc. (MNTA)
0.52%
Acorda Therapeutics Inc. (ACOR)
0.51%
Intellia Therapeutics Inc. (NTLA)
0.51%
Vanda Pharmaceuticals Inc. (VNDA)
0.5%
Dynavax Technologies Corporation (DVAX)
0.46%
Epizyme Inc. (EPZM)
0.45%
Xencor Inc. (XNCR)
0.39%
G1 Therapeutics Inc. (GTHX)
0.39%
TG Therapeutics Inc. (TGTX)
0.36%
Progenics Pharmaceuticals Inc. (PGNX)
0.34%
Karyopharm Therapeutics Inc. (KPTI)
0.34%
Novavax Inc. (NVAX)
0.34%
Retrophin Inc. (RTRX)
0.33%
Fate Therapeutics Inc. (FATE)
0.33%
MacroGenics Inc. (MGNX)
0.32%
CytomX Therapeutics Inc. (CTMX)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.3%
Denali Therapeutics Inc. (DNLI)
0.3%
Deciphera Pharmaceuticals Inc. (DCPH)
0.28%
Rigel Pharmaceuticals Inc. (RIGL)
0.26%
Prothena Corp. Plc (PRTA)
0.25%
ArQule Inc. (ARQL)
0.22%
Sorrento Therapeutics Inc. (SRNE)
0.22%
PDL BioPharma Inc. (PDLI)
0.21%
Five Prime Therapeutics Inc. (FPRX)
0.18%
GlycoMimetics Inc. (GLYC)
0.18%
BioCryst Pharmaceuticals Inc. (BCRX)
0.18%
ZIOPHARM Oncology Inc. (ZIOP)
0.18%
Athenex Inc. (ATNX)
0.17%
Allakos Inc. (ALLK)
0.17%
Inovio Pharmaceuticals Inc. (INO)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.16%
Rhythm Pharmaceuticals Inc. (RYTM)
0.16%
Achillion Pharmaceuticals Inc. (ACHN)
0.15%
Stemline Therapeutics Inc. (STML)
0.15%
Kura Oncology Inc. (KURA)
0.14%
Apellis Pharmaceuticals Inc. (APLS)
0.13%
Lexicon Pharmaceuticals Inc. (LXRX)
0.11%
Solid Biosciences Inc. (SLDB)
0.11%
Cytokinetics Incorporated (CYTK)
0.09%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.04%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%
XBI Technicals
Alpha
-8
Beta
1.65
Leverage
Long
Standard Deviation
8.58
XBI Dividends
Dividend Date
2018-12-21
Latest Dividend
0.012
Annual Dividend
0.2
Annual Dividend Rate
0.2
Annual Dividend Yield
0.24
XBI Performance
YTD Return
19.5%
1 Year Return
-5.96%
3 Year Return
73.56%
5 Year Return
57.11%
10 Year Return
455.79%
XBI Related Articles
Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook
Healthcare ETFs weakened Wednesday after Abbot Laboratories (NYSE: ABT) slipped on a revenue miss and revealed an uninspiring forecast for…
Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology
Biotechnology stocks and sector-related ETFs were among the best performers Monday after Eli Lilly (NYSE: LLY) said it will acquire…
Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat
Stocks rallied Wednesday, a day after one of the most contentious midterm elections in U.S. history. In Tuesday’s midterm elections,…
Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend
Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and…
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has…